glucagon has been researched along with Mesothelioma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gómez Gómez, LA; Losada López, I; Masmiquel Comas, L; Nicolau Ramis, JA; Rodríguez Rodríguez, I | 1 |
Ghazvinian, S; Marks, LJ; Rossini, AA; Sawin, CT; Silbert, CK; Widrich, WC | 1 |
Boyle, C; Drapanas, T; Field, JB; Remer, A | 1 |
3 other study(ies) available for glucagon and Mesothelioma
Article | Year |
---|---|
[Glucagon perfusion in paraneoplastic hypoglycemia].
Topics: Antineoplastic Agents; Coma; Fatal Outcome; Female; Glucagon; Humans; Hypoglycemia; Infusions, Intravenous; Insulin-Like Growth Factor II; Mesothelioma; Middle Aged; Models, Biological; Palliative Care; Paraneoplastic Syndromes; Perfusion; Peritoneal Neoplasms; Protein Precursors; Recurrence | 2009 |
Tumor hypoglycemia: deficient splanchnic glucose output and deficient glucagon secretion.
Topics: Glucagon; Glucose; Hypoglycemia; Insulin; Liver; Mesothelioma; Pancreas; Thoracic Neoplasms | 1976 |
Clinical and physiologic studies using diazoxide in the treatment of hypoglycemia.
Topics: Abdominal Neoplasms; Adenoma, Islet Cell; Adult; Animals; Blood Glucose; Diazoxide; Dogs; Female; Glucagon; Glucose; Humans; Hydrocortisone; Hypoglycemia; Insulin; Liver Neoplasms; Male; Mesothelioma; Middle Aged; Neoplasm Metastasis; Pancreas; Regional Blood Flow; Trichlormethiazide | 1968 |